Journal of Clinical Pharmacology

Aims & Scope

The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology.

This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics.

Additionally, JCP publishes review articles, commentaries and educational manuscripts.

The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.3
2024	2.40

SJR (SCImago Journal Rank)

Year	Value
2024	0.756

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	133

Journal Rank

Year	Value
2024	7315

Journal Citation Indicator

Year	Value
2024	1367

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

  Citation: 1088

  Authors: Limin, Zhong, Moses Sing Sum

• A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

  Citation: 631

  Authors: E. M. VAUGHAN

• The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

  Citation: 542

  Authors: Ryan M., Brian C., Paul J., Bruce G., Kennith R.

• Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans

  Citation: 503

  Authors: Eva U., Joerg, Silke, Anne‐Kathrin, Bernhard, Bernd, Holger, Gisela, Hartmut, Markus

• A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

  Citation: 501

  Authors: Marilyn N., Gordon L.

• Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

  Citation: 420

  Authors: Jessie, Adele, Priya, Suliman, Monica, Ramesh, Suzanne, Gary, Dean F., Arco Y., Tsu‐Han, Weiyi, William P.

• DHEA and DHEA‐S: A Review

  Citation: 415

  Authors: Patricia D., Firoozeh S., Amy L., Tanya J., Reginald F.

• Cannabidiol: An Overview of Some Pharmacological Aspects

  Citation: 371

  Authors: Raphael, Linda A., Ruth

• Global Burden of Disease (GBD) for Hepatitis C

  Citation: 371

  Authors:

• Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

  Citation: 365

  Authors: Koichiro, Jeanne, Masaya, Hiroshi, Toshihiro, Masazumi, Satoshi

---